Paraoxonase-1 is a better indicator than HDL of Atherosclerosis - A pilot study in North Indian population

被引:7
|
作者
Singh, Kamna [1 ]
Singh, Ritu [1 ]
Chandra, Sudhir [1 ]
Tyagi, Sanjay [2 ]
机构
[1] Lady Hardinge Med Coll & Hosp, Dept Biochem, Shaheed Bhagat Singh Rd,Connaught Pl, New Delhi 110001, India
[2] GB Pant Hosp, Dept Cardiol, New Delhi 110002, India
关键词
Atherosclerosis; High-density lipoproteins; Paraoxonase-1; PON-1;
D O I
10.1016/j.dsx.2017.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The present study aims to evaluate the levels of HDL and Paraoxonase-1 (PON1) and their correlation in atherosclerotic patients with and without diabetic mellitus (DM) as well as in control subjects in Northern Indian population. Materials and methods: We analyzed lipid profiles and Serum PON1 levels by automated analyzer and ELISA, respectively. Study subjects (N=150) were divided in three groups; Group I: Atherosclerotic patients without DM (N=50), Group II: Atherosclerotic patients with DM (N=50); Group III: Controls (N=50). Results: We found a significantly (p<0.0001) low levels of HDL-C in Group I (32.2 +/- 7.3) and Group II (36.9 +/- 11.5) as compared to Group III (41.0 +/- 7.1). PON-1 levels were also significantly lower in Group I (60.1 +/- 10.5) and Group II (50.0 +/- 13.9) when compared to Group III (95.0 +/- 12.0). We observed a significant correlation (r=0.59, p<0.001) between the levels of PON1 and HDL-C in study subjects. Conclusions: The reduced levels of HDL and PON-1 and their significant correlation in CAD patients may be associated with the pathogenesis of this disease. Considering HDL as a dependent variable, Paraoxonase-1 is the most important parameter contributing to the total variation in HDL in CAD. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:275 / 278
页数:4
相关论文
共 50 条
  • [1] HIGH PARAOXONASE-1 HDL IS MORE EFFECTIVE THAN LOW PARAOXONASE-1 HDL IN IMPEDING LDL OXIDATION IN VITRO
    Hama, S.
    Soran, H.
    Albeck, S.
    Charlton-Menys, V.
    Yadav, R.
    Liu, Y.
    France, M.
    Tawfiq, D.
    Durrington, P.
    ATHEROSCLEROSIS, 2012, 223 (02) : 529 - 529
  • [2] Association of paraoxonase-1 gene polymorphisms with insulin resistance in South Indian population
    Gomathi, Panneerselvam
    Iyer, Anandi Chandramouli
    Murugan, Ponniah Senthil
    Sasikumar, Sundaresan
    Raj, Nancy Bright Arul Joseph
    Ganesan, Divya
    Nallaperumal, Sivagnanam
    Murugan, Maruthamuthu
    Selvam, Govindan Sadasivam
    GENE, 2018, 650 : 55 - 59
  • [3] Lactonase activity of paraoxonase-1 in multiple sclerosis patients: a pilot study
    Jamroz-Wisniewska, A.
    Beltowski, J.
    Stelmasiak, Z.
    Bartosik-Psujek, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 360 - 360
  • [4] Paraoxonase-1 polymorphisms and cerebral ischemic stroke: pilot study in mexican patients
    Fernanda Martinez-Salazar, Maria
    de la Luz Soriano-Martinez, Maria
    Juantorena-Ugas, Alina
    Almenares-Lopez, Damianys
    Yescas, Petra
    Boll, Marie-Catherine
    Monroy-Noyola, Antonio
    COLOMBIA MEDICA, 2018, 49 (03): : 223 - 227
  • [5] Black Elderberry Extract Improves Serum HDL-cholesterol and Paraoxonase-1 Activity in Atherosclerosis-Prone Mice
    Millar, Courtney L.
    Winter, Heather
    Georgelos, Jamie
    Norris, Gregory H.
    Park, Young-Ki
    Blesso, Christopher N.
    FASEB JOURNAL, 2017, 31
  • [6] Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel
    Halim, Hasseri
    Pinkaew, Decha
    Chunhacha, Preedakorn
    Sinthujaroen, Patuma
    Thiagarajan, Perumal
    Fujise, Ken
    PLOS ONE, 2019, 14 (06):
  • [7] Paraoxonase 1: A better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus
    Patra, Surajeet Kumar
    Singh, Kamna
    Singh, Ritu
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (02) : 108 - 111
  • [8] Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study
    Bains, Yasmin
    Caccavello, Russell
    Kotani, Kazuhiko
    Gugliucci, Alejandro
    ANTIOXIDANTS, 2019, 8 (06)
  • [9] Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population
    Gupta, Nidhi
    Binukumar, B. K.
    Singh, Surjit
    Sunkaria, Aditya
    Kandimalla, Ramesh
    Bhansali, Anil
    Gill, Kiran Dip
    GENE, 2011, 487 (01) : 88 - 95
  • [10] Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects
    Dullaart, Robin P. F.
    Otvos, James D.
    James, Richard W.
    CLINICAL BIOCHEMISTRY, 2014, 47 (12) : 1022 - 1027